Literature DB >> 28840382

New photobiomodulation protocol prevents oral mucositis in hematopoietic stem cell transplantation recipients-a retrospective study.

Camila Weissheimer1, Marina Curra2,3, Lauro J Gregianin4, Liane E Daudt5, Vivian P Wagner2, Marco Antonio T Martins2,3, Manoela D Martins6,7,8.   

Abstract

Oral mucositis (OM) is an adverse side effect among hematopoietic stem cell transplantation (HSCT) recipients. The objective of this retrospective study was to evaluate the preventive effect of photobiomodulation (PBM) applied three times per week versus seven times per week in patients undergoing HSCT. The risk factors related to the incidence and severity of OM were also assessed. This was a retrospective study that evaluated 99 HSCT recipients who received different PBM protocols. Group I received three sessions per week, and group II received daily treatment. PBM was applied using a continuous-wave diode laser (InGaAlP; MM Optics, São Carlos, SP, Brazil) at a wavelength of 660 nm (visible-red) and a total radiant energy of 0.24 J per point. The baseline disease, type of transplant, type of conditioning, prophylaxis against graft-versus-host disease, OM grade, absolute leukocyte and platelet counts, and levels of liver and renal function markers were collected from medical records. The patients' age ranged from 13 to 71 years (mean/SD, 40.54 ± 16.45). No significant difference was observed between groups I and II regarding sex, age, ethnic, diagnosis, donor type, and conditioning treatment. Both PBM protocols were equally efficient in preventing OM (p = 0.34, ANOVA). Independent of the PBM protocol used, patients who received allogeneic transplant (p < 0.01-Fischer's exact test), total body irradiation (TBI-12Gy) (p = 0.01-chi-square test), busulfan + cyclophosphamide (p < 0.01-chi-square test), or methotrexate-containing regimens (p < 0.01-Fischer's exact test) demonstrated higher OM incidence and severity. Myelosuppression (p < 0.01-Mann-Whitney test) and impaired renal function (p = 0.02-Mann-Whitney test) were also considered risk factors for OM. Based on this retrospective data, PBM was effective in preventing OM in patients undergoing HSCT even when it was applied three times a week. A prospective study might be necessary to confirm these findings.

Entities:  

Keywords:  Adverse effects; Continuous-wave diode laser; Low-level laser; Oncology; Preventive therapy

Mesh:

Year:  2017        PMID: 28840382     DOI: 10.1007/s10103-017-2314-7

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  54 in total

1.  Influence of different energy densities of laser phototherapy on oral wound healing.

Authors:  Vivian Petersen Wagner; Luise Meurer; Marco Antonio Trevizani Martins; Chris Krebs Danilevicz; Alessandra Selinger Magnusson; Márcia Martins Marques; Manoel Sant'Ana Filho; Cristiane Helena Squarize; Manoela Domingues Martins
Journal:  J Biomed Opt       Date:  2013-12       Impact factor: 3.170

2.  Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation.

Authors:  Ana Chor; Sandra R Torres; Angelo Maiolino; Marcio Nucci
Journal:  Eur J Haematol       Date:  2009-08-13       Impact factor: 2.997

3.  Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation.

Authors:  Letícia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques da Graça Lopes; Maria Gabriela Haye Biazevic; Carlos de Paula Eduardo; Luciana Correa; Nelson Hamerschlak; Edgard Michel-Crosato
Journal:  Hematol Oncol       Date:  2013-04-29       Impact factor: 5.271

Review 4.  Effect of low-level laser irradiation on proliferation of human dental mesenchymal stem cells; a systemic review.

Authors:  Ali Borzabadi-Farahani
Journal:  J Photochem Photobiol B       Date:  2016-07-25       Impact factor: 6.252

5.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

Review 6.  Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients.

Authors:  Cesar Migliorati; Ian Hewson; Rajesh V Lalla; Heliton Spindola Antunes; Cherry L Estilo; Brian Hodgson; Nilza Nelly Fontana Lopes; Mark M Schubert; Joanne Bowen; Sharon Elad
Journal:  Support Care Cancer       Date:  2012-09-22       Impact factor: 3.603

Review 7.  The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.

Authors:  Hafsa M Chaudhry; Alison J Bruce; Robert C Wolf; Mark R Litzow; William J Hogan; Mrinal S Patnaik; Walter K Kremers; Gordon L Phillips; Shahrukh K Hashmi
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-26       Impact factor: 5.742

8.  Effect of laser phototherapy in the prevention and treatment of chemo-induced mucositis in hamsters.

Authors:  Talita Christine Camilo Lopez; Manoela Domingues Martins; Vanessa Christina Santos Pavesi; Leila Soares Ferreira; Sandra Kalil Bussadori; Maria Stella Moreira; Márcia Martins Marques
Journal:  Braz Oral Res       Date:  2013-06-11

9.  Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.

Authors:  Karin Garming Legert; Mats Remberger; Olle Ringdén; Anders Heimdahl; Göran Dahllöf
Journal:  Support Care Cancer       Date:  2014-03-20       Impact factor: 3.603

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

View more
  8 in total

1.  Is photobiomodulation therapy effective in reducing pain caused by toxicities related to head and neck cancer treatment? A systematic review.

Authors:  Mariana de Pauli Paglioni; Carolina Guimarães Bonfim Alves; Elisa Kauark Fontes; Marcio Ajudarte Lopes; Ana Carolina Prado Ribeiro; Thaís Bianca Brandão; Cesar Augusto Migliorati; Alan Roger Santos-Silva
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

Review 2.  Photobiomodulation and Cancer: What Is the Truth?

Authors:  Michael R Hamblin; Scott T Nelson; Justin R Strahan
Journal:  Photomed Laser Surg       Date:  2018-02-21       Impact factor: 2.796

3.  Comparison of photobiomodulation using either an intraoral or an extraoral laser on oral mucositis induced by chemotherapy in rats.

Authors:  Stéfanie Thieme; Julia Turra Ribeiro; Bernardo Gindri Dos Santos; Renata de Almeida Zieger; Mara Luana Batista Severo; Marco Antonio Trevizani Martins; Cristiane Matté; Manoela Domingues Martins
Journal:  Support Care Cancer       Date:  2019-06-04       Impact factor: 3.603

4.  Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial.

Authors:  Mariana Bitu Ramos-Pinto; Teresa Paula de Lima Gusmão; Jayr Schmidt-Filho; Graziella Chagas Jaguar; Manoela Domingues Martins; Fábio Abreu Alves
Journal:  Support Care Cancer       Date:  2021-04-27       Impact factor: 3.603

5.  Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy.

Authors:  Marina Curra; Amanda F Gabriel; Maria Beatriz C Ferreira; Marco Antonio T Martins; André T Brunetto; Lauro J Gregianin; Manoela Domingues Martins
Journal:  Support Care Cancer       Date:  2021-04-12       Impact factor: 3.603

Review 6.  Review of a three-year study on the dental care of onco-hematological pediatric patients.

Authors:  Alexandre Viana Frascino; Marcelo Fava; Louise Cominato; Vicente Odone-Filho
Journal:  Clinics (Sao Paulo)       Date:  2018-12-03       Impact factor: 2.365

Review 7.  An Overview of Clinical Oncology and Impact on Oral Health.

Authors:  Jack A Harris; Giulia Ottaviani; Nathaniel S Treister; Glenn J Hanna
Journal:  Front Oral Health       Date:  2022-04-25

8.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.